Pfizer's chairman says it's not clear whether people who are vaccinated can still spread COVID-19




 
  • Pfizer's CEO said it's not clear if the company's coronavirus vaccine will no longer be able to spread the virus to other people.

  • Albert Bourla told NBC's "Dateline": "I think this is something that needs to be examined. We are not certain about that right now with what we know."

  • Independent researchers have already made it clear that the trials used to test the vaccine did not examine its effects on transmission.

  • The US could approve Pfizer's vaccine on December 10. It is already approved in the UK.

  • Visit Business Insider's homepage for more stories.

The chairman of Pfizer said it's not clear whether people who have taken the company's coronavirus vaccine will still be able to spread the virus to other people.

Albert Bourla told NBC's "Dateline" that more studies had to be done into whether someone who had been vaccines could still transmit the coronavirus.

Host Lester Holt asked Bourla: "Even though I've had the protection, am I still able to transmit it to other people?"

Bourla then responded: "I think this is something that needs to be examined. We are not certain about that right now with what we know."

The vaccine was developed jointly by Pfizer and the smaller firm BioNTech.

Researchers who were not involved in the vaccine's development already highlighted how the company's trials - and those run by other companies producing coronavirus vaccines - did not assess whether the vaccine affects how the virus spreads.

It raises the possibility that vaccinated people could still pass the disease to others.

The answer to the question will have a profound effect on how authorities deal with the pandemic after a vaccine arrives.

As Business Insider's Andrew Dunn previously reported, top researchers are pitching additional studies on the topic to Pfizer and Moderna. 

Pfizer and BioNTech announced last month that their vaccine was 95% effective at preventing COVID-19.

The US Food and Drug Administration (FDA ) is assembling independent experts on December 10 to evaluate the vaccine, and a decision on whether the US is authorizing the vaccine could come the same day.

The UK has already approved Pfizer and BioNTech's vaccine for use.

The top scientist advising Operation Warp Speed, the US government vaccine rollout program, predicted this week that more than 100 million Americans would be vaccinated against COVID-19 within the next 100 days.

COMMENTS

More Related News

A former Houston cop charged with storming the US Capitol changed his story in an interview with the feds. Now he says he was there to see
A former Houston cop charged with storming the US Capitol changed his story in an interview with the feds. Now he says he was there to see 'historical art'
  • US
  • 2021-01-23 02:53:28Z

So far, more than a dozen off-duty police officers have been investigated or charged on suspicion of taking part in the violent riot at the Capitol.

WHO panel to issue recommendations on Moderna vaccine next week
WHO panel to issue recommendations on Moderna vaccine next week
  • US
  • 2021-01-22 22:09:27Z

An independent panel of vaccine experts has reviewed data from Moderna Inc's COVID-19 vaccine and will make public its recommendations on the vaccine's use...

A Texas doctor has been charged with stealing 9 doses of the COVID-19 vaccine
A Texas doctor has been charged with stealing 9 doses of the COVID-19 vaccine 'for friends and family'
  • US
  • 2021-01-22 20:52:19Z

"He abused his position to place his friends and family in line in front of people who had gone through the lawful process to be there," the DA said.

CDC Says Virus Patients Can Be Switched to Another Vaccine for Second Dose
CDC Says Virus Patients Can Be Switched to Another Vaccine for Second Dose

The Centers for Disease Control and Prevention has quietly changed its recommendations for coronavirus immunizations to allow patients to switch the...

Mali picks AstraZeneca COVID-19 vaccine for 4.2 million people
Mali picks AstraZeneca COVID-19 vaccine for 4.2 million people
  • US
  • 2021-01-22 19:48:55Z

Mali has chosen to use the AstraZeneca COVID-19 vaccine in its plan to initially immunise 4.2 million people, targeting medical staff, the elderly and those ...

Leave a Comment

Your email address will not be published. Required fields are marked with *

Cancel reply

Comments

Top News: Latin America